The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age

NCT02636868 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Distress Syndrome

Interventions

DRUG: Lucinactant delivered via investigational delivery device
DRUG: nCPAP

Sponsor

Windtree Therapeutics